As of April 9, 2026, the CDC reports 1,714 confirmed measles cases in the United States this year, with 94% outbreak-associated across 33 jurisdictions and 17 new outbreaks ignited mainly by unvaccinated travelers importing the highly contagious virus (R0 of 12–18) from global hotspots. Declining MMR vaccination coverage—92.5% among kindergartners in the 2024–2025 school year, below the 95% herd immunity threshold—has enabled sustained transmission in under-vaccinated communities, threatening the U.S.'s elimination status achieved in 2000. Traders should monitor weekly CDC updates and Morbidity and Mortality Weekly Reports for case surges, especially amid spring travel and school reopenings, as epidemiological trajectories could accelerate totals by year-end.
Polymarket verilerine atıfta bulunan deneysel AI tarafından oluşturulmuş özet. Bu bir işlem tavsiyesi değildir ve bu piyasanın nasıl çözümlendiğinde hiçbir rolü yoktur. · Güncellendi2026 'da ABD'de kızamık vakaları mı?
2026 'da ABD'de kızamık vakaları mı?
$7,595,303 Hac.
$7,595,303 Hac.
31 Ara 2026
↑2k
99%
↑3k
83%
↑4k
59%
↑5k
40%
↑7,5k
14%
↑10k
13%
↑12,5k
10%
$7,595,303 Hac.
$7,595,303 Hac.
31 Ara 2026
↑2k
$38,130 Hac.
99%
↑3k
$44,581 Hac.
83%
↑4k
$148,314 Hac.
59%
↑5k
$203,157 Hac.
40%
↑7,5k
$159,055 Hac.
14%
↑10k
$6,483,790 Hac.
13%
↑12,5k
$343,513 Hac.
10%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of April 9, 2026, the CDC reports 1,714 confirmed measles cases in the United States this year, with 94% outbreak-associated across 33 jurisdictions and 17 new outbreaks ignited mainly by unvaccinated travelers importing the highly contagious virus (R0 of 12–18) from global hotspots. Declining MMR vaccination coverage—92.5% among kindergartners in the 2024–2025 school year, below the 95% herd immunity threshold—has enabled sustained transmission in under-vaccinated communities, threatening the U.S.'s elimination status achieved in 2000. Traders should monitor weekly CDC updates and Morbidity and Mortality Weekly Reports for case surges, especially amid spring travel and school reopenings, as epidemiological trajectories could accelerate totals by year-end.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Piyasa Açıldı: Feb 16, 2026, 11:51 AM ET
Hacim
$7,595,303Bitiş Tarihi
31 Ara 2026Piyasa Açıldı
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of April 9, 2026, the CDC reports 1,714 confirmed measles cases in the United States this year, with 94% outbreak-associated across 33 jurisdictions and 17 new outbreaks ignited mainly by unvaccinated travelers importing the highly contagious virus (R0 of 12–18) from global hotspots. Declining MMR vaccination coverage—92.5% among kindergartners in the 2024–2025 school year, below the 95% herd immunity threshold—has enabled sustained transmission in under-vaccinated communities, threatening the U.S.'s elimination status achieved in 2000. Traders should monitor weekly CDC updates and Morbidity and Mortality Weekly Reports for case surges, especially amid spring travel and school reopenings, as epidemiological trajectories could accelerate totals by year-end.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Hacim
$7,595,303Bitiş Tarihi
31 Ara 2026Piyasa Açıldı
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...As of April 9, 2026, the CDC reports 1,714 confirmed measles cases in the United States this year, with 94% outbreak-associated across 33 jurisdictions and 17 new outbreaks ignited mainly by unvaccinated travelers importing the highly contagious virus (R0 of 12–18) from global hotspots. Declining MMR vaccination coverage—92.5% among kindergartners in the 2024–2025 school year, below the 95% herd immunity threshold—has enabled sustained transmission in under-vaccinated communities, threatening the U.S.'s elimination status achieved in 2000. Traders should monitor weekly CDC updates and Morbidity and Mortality Weekly Reports for case surges, especially amid spring travel and school reopenings, as epidemiological trajectories could accelerate totals by year-end.
Polymarket verilerine atıfta bulunan deneysel AI tarafından oluşturulmuş özet. Bu bir işlem tavsiyesi değildir ve bu piyasanın nasıl çözümlendiğinde hiçbir rolü yoktur. · Güncellendi
Harici bağlantılara dikkat edin.
Harici bağlantılara dikkat edin.
Sıkça Sorulan Sorular